cancer pain News
Most Popular cancer pain Story
Cephalon takes heat for off-label narcotic promotion
Connecticut Attorney General Richard Blumenthal has determined that Cephalon "engaged in questionable practices" to increase sales of the narcotic painkiller lollipop Actiq. The drug, which is FDA-approved only for use in treating cancer pain, is widely prescribed for conditions such as migraines and backache as well. With a growing number of patients becoming addicted to Actiq, which contains fentanyl, government regulators and physicians were concerned that marketing tactics were …
Read more...Latest Headlines
- April 8, 2008
- February 6, 2008
- November 20, 2006
- October 10, 2006
- September 26, 2006
- September 4, 2006
- June 29, 2006
- March 5, 2006
- January 3, 2006
- July 18, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
